Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 8, 1996, Pages 713-721

  Ayers, Gregory M ^b   Rho, Tai H ^b   Ben David, Joseph ^b   Besch Jr, Henry R ^b   Zipes, Douglas P ^a  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

amiodarone; antiarrhythmic drugs; atrial fibrillation; electrophysiology; targeted therapy; tissue drug concentrations

Indexed keywords

AMIODARONE; CHLORALOSE; GLUCOSE; POLYSORBATE 80;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; FEMALE; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART ELECTROPHYSIOLOGY; INTRACARDIAC DRUG ADMINISTRATION; MALE; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; REFRACTORY PERIOD; STERNOTOMY;

EID: 0029764326     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00579.x     Document Type: Article

References (24)

1. 131I therapy for Graves disease. N Engl J Med 1984;311: 426.
2. Papac RJ. In Pradham SN, ed: Pharmacology in Medicine: Principles and Practice. SP Press International, Bethesda, 1986, pp. 924-925.
3. Krukemyer JJ, Talbert RL: Lovastatin: A new cholesterol-lowering agent. Pharmacotherapy 1987;7:198-210.
4. Ahlquist RP: A study of the adrenoreceptor receptors. Am J Physiol 1948;153:586
5. Cairncross JG: Tumors of the central nervous system. In Kelly WN, ed: Textbook of Internal Medicine. JB Lippincott, Philadelphia, 1992, pp. 2183-2189.
6. Anderson JL, Marshall HW, Bray BE, et al: A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 1983;308:1312-1318.
7. Miyazaki T, Pride HP, Zipes DP: Prostaglandins in the pericardial fluid modulate neural regulation of cardiac electrophysiological properties. Circ Res 1990;66:163-175.
8. Munoz A, Karila P, Gallay P, et al: A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. Eur Heart J 1988;9:142-148.
9. Millard RW, Biag H, Vatner SF: Cardiovascular effects of radioactive microsphere suspensions and Tween 80 solutions. Am J Physiol 1977;232:H331-H334.
10. Platou ES, Refsum H: Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog. Acta Pharmacol Toxicol 1986;58:163-168.
11. Torres-Arraut E, Singh S, Pickoff AS: Electrophysiologic effects of Tween 80 in the myocardium and specialized conduction system of the canine heart. J Electrocardiol 1984;17:145-152.
12. Kannan R, Miller S, Ferez V, et al: Sensitive method for the measurement of amiodarone and desethylamiodarone in serum and tissue and its application to disposition studies. Chromatography 1987;385:225-232.
13. Moor MJ, Wyss PA, Bickel MH: New procedure for the high-performance liquid Chromatographic determination of amiodarone and desethylamiodarone with solid-phase extraction of rat plasma and tissue samples. Chromatography 1988;431:455-460.
14. Adams PC, Holt DW, Storey GCA, et al: Amiodarone and its desethyl metabolite: Tissue distribution and morphologic changes during long-term therapy. Circulation 1985;72:1064-1075.
15. Brien JF, Jimmo S, Brennan FJ, et al: Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol 1987;65:360-364.
16. Bandyopadhyah S, Somani P: A comparison of plasma, white blood cell, red blood cell, and tissue distribution of amiodarone and desethylamiodarone in anesthetized dogs. J Cardiovasc Pharmacol 1987;10:379-388.
17. Zipes DP, Prystowsky EN, Heger JJ: Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 1984;3:1059-1071.
18. Heger JJ, Prystowsky EN, Miles WM, et al: Clinical use and pharmacology of amiodarone. Med Clin North Am 1984;68:1339-1366.
19. Drinker CK, Field ME: Absorption from the pericardial cavity. J Exp Med 1931;53:143-152.
20. Stewart HJ, Crane NF, Deitrick JE: Absorption from the pericardial cavity in man. Am Heart J 1938;16:198-202.
21. Weinberg BA, Miles WM, Klein LS, et al: Five year follow-up of 589 patients treated with amiodarone. Am Heart J 1993;125:109-120.
22. Dusman RE, Stanton MS, Miles WM, et al: Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-59.
23. Miller AJ: Lymphatics of the Heart. Raven Press, New York, 1982, pp. 165-180.
24. Zipes DP: Targeted drug therapy. Circulation 1990;81:1139-1141.